KRM-III is an orally active T cell antigen receptor (TCR) inhibitor with anti-inflammatory activity that potently inhibits TCR and myristate acetate/fosfomycin/ionomycin-induced NFAT nuclear factor activation and T cell proliferation, with an IC50 of approximately 5 µM.
Molecular Weight:
252.33
Purity:
99.97%
CAS Number:
[79220-94-3]
Formula:
C15H12N2S
Target:
Others
T35885
* VAT and and shipping costs not included. Errors and price changes excepted